Effects of Gentiana lutea Root on Vascular Diseases
No Thumbnail
Authors
Joksić, Gordana
Radak, Đorđe J.
Sudar-Milovanović, Emina

Obradović, Milan M.

Radovanović, Jelena V.

Isenović, Esma R.

Review (Published version)

© 2021 Bentham Science Publishers
Metadata
Show full item recordAbstract
Background: Gentiana lutea (GL), commonly known as yellow gentian, bitter root, and bit-terwort, belongs to family Gentianaceae. GL belongs to genus Gentiana, which is a rich natural source of iridoids, secoiridoids, xantones, flavonoids, triterpenoids, and carbohydrates. Medicinal plants from Gentiana species have anti-oxidant, anti-inflammatory, anti-mitogenic, anti-proliferative, and lipid-lowering effects, as well as a cardioprotective, hypotensive, vasodilator and anti-platelet activities. Objective: We reviewed the recent literature related to the effects of Gentiana species, and their active components on vascular diseases. Methods: Data used for this review were obtained by searching the electronic database [PUB-MED/MEDLINE 1973-February 2020]. The primary data search terms of interest were: Gentiana lutea, Gentienacea family, phytochemistry, vascular diseases, treatment of vascular diseases, anti-oxidant, anti-inflammatory, anti-atherogenic. Conclusion: Gentiana species and th...eir constituents affect many different factors related to vascular disease development and progression. Therefore, Gentiana-based therapeutics represent potentially use-ful drugs for the management of vascular diseases. © 2021 Bentham Science Publishers.
Keywords:
Anti-atherogenic / Anti-inflammatory / Anti-oxidant / Gentiana lutea / Gentienacea family / Phytochemistry / Treatment of vascular diseases / Vascular diseasesSource:
Current Vascular Pharmacology, 2021, 19, 4, 359-369Funding / projects:
- Ministry of Education, Science and Technological Development of the Republic of Serbia
- Impact of agents with potential use in functional foods on biomarkers for induction of age related diseases (EU-245030)
DOI: 10.2174/1570161118666200529111314
ISSN: 1570-1611
PubMed: 32469702
WoS: 000620378200003
Scopus: 2-s2.0-85103683802
Collections
Institution/Community
VinčaTY - JOUR AU - Joksić, Gordana AU - Radak, Đorđe J. AU - Sudar-Milovanović, Emina AU - Obradović, Milan M. AU - Radovanović, Jelena V. AU - Isenović, Esma R. PY - 2021 UR - https://vinar.vin.bg.ac.rs/handle/123456789/9407 AB - Background: Gentiana lutea (GL), commonly known as yellow gentian, bitter root, and bit-terwort, belongs to family Gentianaceae. GL belongs to genus Gentiana, which is a rich natural source of iridoids, secoiridoids, xantones, flavonoids, triterpenoids, and carbohydrates. Medicinal plants from Gentiana species have anti-oxidant, anti-inflammatory, anti-mitogenic, anti-proliferative, and lipid-lowering effects, as well as a cardioprotective, hypotensive, vasodilator and anti-platelet activities. Objective: We reviewed the recent literature related to the effects of Gentiana species, and their active components on vascular diseases. Methods: Data used for this review were obtained by searching the electronic database [PUB-MED/MEDLINE 1973-February 2020]. The primary data search terms of interest were: Gentiana lutea, Gentienacea family, phytochemistry, vascular diseases, treatment of vascular diseases, anti-oxidant, anti-inflammatory, anti-atherogenic. Conclusion: Gentiana species and their constituents affect many different factors related to vascular disease development and progression. Therefore, Gentiana-based therapeutics represent potentially use-ful drugs for the management of vascular diseases. © 2021 Bentham Science Publishers. T2 - Current Vascular Pharmacology T1 - Effects of Gentiana lutea Root on Vascular Diseases VL - 19 IS - 4 SP - 359 EP - 369 DO - 10.2174/1570161118666200529111314 ER -
@article{ author = "Joksić, Gordana and Radak, Đorđe J. and Sudar-Milovanović, Emina and Obradović, Milan M. and Radovanović, Jelena V. and Isenović, Esma R.", year = "2021", abstract = "Background: Gentiana lutea (GL), commonly known as yellow gentian, bitter root, and bit-terwort, belongs to family Gentianaceae. GL belongs to genus Gentiana, which is a rich natural source of iridoids, secoiridoids, xantones, flavonoids, triterpenoids, and carbohydrates. Medicinal plants from Gentiana species have anti-oxidant, anti-inflammatory, anti-mitogenic, anti-proliferative, and lipid-lowering effects, as well as a cardioprotective, hypotensive, vasodilator and anti-platelet activities. Objective: We reviewed the recent literature related to the effects of Gentiana species, and their active components on vascular diseases. Methods: Data used for this review were obtained by searching the electronic database [PUB-MED/MEDLINE 1973-February 2020]. The primary data search terms of interest were: Gentiana lutea, Gentienacea family, phytochemistry, vascular diseases, treatment of vascular diseases, anti-oxidant, anti-inflammatory, anti-atherogenic. Conclusion: Gentiana species and their constituents affect many different factors related to vascular disease development and progression. Therefore, Gentiana-based therapeutics represent potentially use-ful drugs for the management of vascular diseases. © 2021 Bentham Science Publishers.", journal = "Current Vascular Pharmacology", title = "Effects of Gentiana lutea Root on Vascular Diseases", volume = "19", number = "4", pages = "359-369", doi = "10.2174/1570161118666200529111314" }
Joksić, G., Radak, Đ. J., Sudar-Milovanović, E., Obradović, M. M., Radovanović, J. V.,& Isenović, E. R.. (2021). Effects of Gentiana lutea Root on Vascular Diseases. in Current Vascular Pharmacology, 19(4), 359-369. https://doi.org/10.2174/1570161118666200529111314
Joksić G, Radak ĐJ, Sudar-Milovanović E, Obradović MM, Radovanović JV, Isenović ER. Effects of Gentiana lutea Root on Vascular Diseases. in Current Vascular Pharmacology. 2021;19(4):359-369. doi:10.2174/1570161118666200529111314 .
Joksić, Gordana, Radak, Đorđe J., Sudar-Milovanović, Emina, Obradović, Milan M., Radovanović, Jelena V., Isenović, Esma R., "Effects of Gentiana lutea Root on Vascular Diseases" in Current Vascular Pharmacology, 19, no. 4 (2021):359-369, https://doi.org/10.2174/1570161118666200529111314 . .